Skip to main content

Table 2 Baseline clinical and treatment related characteristics of children on ART at University of Gondar Comprehensive Specialized Hospital, 2017 (n = 402)

From: Late antiretroviral therapy initiation and associated factors among children on antiretroviral therapy at University of Gondar Comprehensive Specialized Hospital, Gondar, Northwest Ethiopia: a cross-sectional study

Variables Frequency (n) Percentage (%)
Duration between HIV test confirmed and enrollment
 < 6 months 291 72.4
 6–12 months 46 11.4
 > 12 months 65 16.2
Any medication before ART initiation
 No 299 74.4
 Yes 103 25.6
Past OI at enrollment
 No 214 53.2
 Yes 188 46.8
Cotrimoxazole prophylaxis
 No 42 10.4
 Yes 360 89.6
INH prophylaxis
 No 338 84.1
 Yes 64 15.9
TB treatment history
 No 336 83.6
 Yes 66 16.4
Chronic disease
 No 324 80.6
 Yes 78 19.4
Immunization status
 Appropriate for age 323 80.3
 Not appropriate for age 67 16.7
 Not Immunized 12 3
WHO stage at HIV test
 I 136 33.8
 II 133 33.1
 III 98 24.4
 IV 35 8.7
Functional status (≥ 5 years)
 Working 120 47.8
 Ambulatory/bedridden 131 52.2
Developmental milestone (< 5 years)
 Appropriate ranges for age 116 76.8
 Developmental delay/regression 35 23.2
CD4 count (> 5 years)
 < 250 cells/mm3 50 20.2
 ≥ 250 cells/mm3 198 79.8
CD4 percentage (≤ 5 years)
 < 15% 37 24.0
 15–25% 39 25.3
 > 25% 78 50.7
WHO stage at ART initiation
 I 94 23.4
 II 136 33.8
 III 130 32.3
 IV 42 10.5
Year of ART initiation
 2007–2008 69 17.2
 2009–2011 137 34.1
 2012–2014 115 28.6
 2015–2016 81 20.1